| 1 |
35086956 | Olaparib-Induced Senescence Is Bypassed through G2-M Checkpoint Override in Olaparib-Resistant Prostate Cancer. | 2022 Apr 1 |
1 |
| 2 |
35163037 | Sesquiterpene Lactones Potentiate Olaparib-Induced DNA Damage in p53 Wildtype Cancer Cells. | 2022 Jan 20 |
2 |
| 3 |
35269669 | Possible Action of Olaparib for Preventing Invasion of Oral Squamous Cell Carcinoma In Vitro and In Vivo. | 2022 Feb 25 |
1 |
| 4 |
33236159 | PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports. | 2021 Jan |
5 |
| 5 |
33970096 | Rapid Response of a BRCA2/TP53/PTEN-Deleted Metastatic Uterine Leiomyosarcoma to Olaparib: A Case Report. | 2021 May |
1 |
| 6 |
34638899 | Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines. | 2021 Sep 29 |
1 |
| 7 |
32526907 | Identifying and Overcoming Mechanisms of PARP Inhibitor Resistance in Homologous Recombination Repair-Deficient and Repair-Proficient High Grade Serous Ovarian Cancer Cells. | 2020 Jun 9 |
1 |
| 8 |
30740957 | Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer. | 2019 Mar |
3 |
| 9 |
29511347 | PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. | 2018 May |
1 |
| 10 |
29783721 | AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations. | 2018 May 19 |
1 |
| 11 |
28069876 | Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer. | 2017 Mar |
1 |
| 12 |
28182994 | ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib. | 2017 Apr |
1 |
| 13 |
28223274 | Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization. | 2017 Aug 1 |
1 |
| 14 |
26975633 | APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines. | 2016 Jun 1 |
3 |
| 15 |
27686740 | Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions. | 2016 Nov 16 |
4 |
| 16 |
24694947 | New insights into PARP inhibitors' effect on cell cycle and homology-directed DNA damage repair. | 2014 Jun |
5 |
| 17 |
24841718 | Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines. | 2014 |
2 |
| 18 |
22416035 | Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53. | 2012 Jun |
4 |
| 19 |
22134241 | Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1. | 2011 Dec 15 |
5 |